$ USD
Description
Blujepa (Gepotidacin 750 mg Tablets)
Blujepa is an FDA-approved antibiotic containing 750 mg of gepotidacin, designed to treat uncomplicated urinary tract infections (uUTIs) in female patients aged 12 years and older who weigh at least 40 kg (88 lbs). It is effective against bacteria such as Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus, and Enterococcus faecalis
Drugs.com
.
Uses of Blujepa
Treats uncomplicated urinary tract infections (uUTIs) caused by susceptible bacteria.
Offers an alternative to traditional antibiotics, especially in cases of antibiotic resistance.
Demonstrated efficacy in clinical trials, showing superior results compared to nitrofurantoin
.
Dosage Information
Recommended dosage: Take two 750 mg tablets (total 1500 mg) orally, twice daily (approximately 12 hours apart), for 5 days.
Administration: Consume after a meal to reduce the possibility of gastrointestinal intolerance
FDA Access Data
.
Missed dose: If a dose is missed, take it as soon as possible. Do not double the dose to make up for a missed dose.
Possible Side Effects
Common side effects may include:
Gastrointestinal issues: Nausea, diarrhea, stomach pain.
Neurological effects: Dizziness, headache.
Skin reactions: Rash or itching.
Serious side effects are rare but may include:
Cardiac symptoms: Irregular heartbeat, fainting.
Severe allergic reactions: Swelling, difficulty breathing.
Seek medical attention if you experience any of these symptoms.
John Smith –
Pretty with plenty of pages, but not enough space for notes relevant to the password account.